Details for Patent: 9,492,443

Which drugs does patent 9,492,443 protect, and when does it expire?

Patent 9,492,443 protects OXAYDO and is included in one NDA.

This patent has thirteen patent family members in six countries.

Summary for Patent: 9,492,443

Title:	Abuse deterrent compositions and methods of making same
Abstract:	This invention relates a therapeutic pharmaceutical composition comprising: a mixture including an opioid; polyethylene oxide in an amount of about 3 to about 40 wt % of the composition; a disintegrant; and a surfactant; wherein the disintegrant is present in an amount sufficient to cause the pharmaceutical composition to exhibit an immediate release profile.
Inventor(s):	Kumar; Vijai (Morris Plains, NJ), Dixon; David (Woodside, NY), Tewari; Divya (West Chester, PA), Wadgaonkar; Dilip B. (Suffern, NY)
Assignee:	ACURA PHARMACEUTICALS, INC. (Palatine, IL)
Application Number:	14/339,143
Patent Claim Types: see list of patent claims	Composition; Dosage form;

Drugs Protected by US Patent 9,492,443

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Zyla	OXAYDO	oxycodone hydrochloride	TABLET;ORAL	202080-001	Jun 17, 2011		DISCN	Yes	No			Y
Zyla	OXAYDO	oxycodone hydrochloride	TABLET;ORAL	202080-002	Jun 17, 2011		DISCN	Yes	No			Y

International Family Members for US Patent 9,492,443

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2004294953
Australia	2010200979
Australia	2013206525
Australia	2015264950
Australia	2017239544
Canada	2547334
European Patent Office	1694260